---
# STRUCTURED METADATA (For Claude Code HTML Generation)
boc_code: "DM05"
boc_category: "BLOOD GLUCOSE MONITORS AND/OR SUPPLIES (NON-MAIL ORDER)"
hcpcs_code: "A4239"
hcpcs_description: "Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (CGM), includes all supplies and accessories, 1 month supply = 1 unit of service"
item_common_name: "Therapeutic CGM Supply Allowance (Replaces K0553)"

# Clinical Classification
clinical_indications:
  - "Diabetes mellitus with insulin treatment OR history of problematic hypoglycemia (Under Review - High Confidence)"
  - "Patient uses non-adjunctive (therapeutic) CGM receiver (E2103) (Under Review - High Confidence)"
  - "CGM prescribed per FDA indications for glycemic control improvement (Under Review - High Confidence)"
  - "Includes sensors, transmitters, and all accessories for 1 month (Under Review - High Confidence)"

icd10_primary:
  - "E10.x - Type 1 diabetes mellitus (Under Review - High Confidence)"
  - "E11.x - Type 2 diabetes mellitus (Under Review - High Confidence)"
  - "O24.x - Gestational diabetes mellitus (Under Review - High Confidence)"
  - "E16.2 - Hypoglycemia, unspecified (Under Review - High Confidence)"

# Coverage Requirements - Structured for comparison tables
medicare:
  covered: true
  prior_auth: "false (Under Review - High Confidence)"
  face_to_face: "In-person/telehealth visit within 6 months prior; every 6 months follow-up to document adherence (Under Review - High Confidence)"
  documentation_type: "SWO with WOPD"
  modifiers: ["CG"]
  frequency_limit: "Maximum 3 units per 90 days (Under Review - High Confidence)"
  quantity_limit: "1 unit = 1 month supply; max 3 units per 90 days (Under Review - High Confidence)"
  special_notes: "REPLACED K0553 effective 1/1/2023. Must be on PDAC Product Classification List. CG modifier when criteria met. Cannot bill standard BGM supplies (A4253, A4259) with therapeutic CGM."

medicaid_nassau:
  covered: true
  prior_auth: true
  dvs_authorization: "DVS authorization required (Under Review - High Confidence)"
  face_to_face: "Compliant data review visits required (Under Review - High Confidence)"
  documentation_type: "Fiscal Order"
  frequency_code: "F9"
  frequency_limit: "Once per month (F9) (Under Review - High Confidence)"
  quantity_limit: "One unit per month maximum (Under Review - High Confidence)"
  special_notes: "DVS authorization required. Frequency F9 (once/month). Encompasses all CGM supplies - sensors, transmitters, accessories. Cannot bill separate BGM supplies."

medicaid_brooklyn:
  covered: true
  prior_auth: true
  dvs_authorization: "DVS authorization required (Under Review - High Confidence)"
  face_to_face: "Compliant data review visits required (Under Review - High Confidence)"
  documentation_type: "Fiscal Order"
  frequency_code: "F9"
  frequency_limit: "Once per month (F9) (Under Review - High Confidence)"
  quantity_limit: "One unit per month maximum (Under Review - High Confidence)"
  special_notes: "Same requirements as Nassau County. DVS authorization required. F9 frequency."

# Quick flags for filtering/searching
requires_prior_auth_any: true
requires_face_to_face_any: true
requires_specialty_eval: "false (Under Review)"
requires_resna_atp: "false (Under Review)"
discontinued: false
replaced_code: "K0553"
replacement_effective_date: "2023-01-01"

# Data Quality Tracking
data_quality:
  primary_source: "DM02, DM05, DM06.md (lines 249-260)"
  source_verified_fields: ["covered", "replaced_code", "replacement_date", "face_to_face_requirements", "modifiers", "frequency_medicare", "frequency_medicaid", "dvs_required"]
  high_confidence_fields: ["clinical_indications", "icd10_primary", "problematic_hypoglycemia_definition", "quantity_limits"]
  needs_verification: ["exact_quantity_per_unit", "requires_specialty_eval"]
  external_searches: []
  field_notes:
    replacement: "Source: 'Replaced K0553 effective 1/1/2023' - Medicare code crosswalk"
    face_to_face: "Source: 'In-person/telehealth visit within 6 months prior; every 6 months follow-up to document adherence'"
    modifiers: "Source: 'CG modifier when criteria met'"
    frequency_medicare: "Source: 'max 3 units per 90 days'"
    frequency_medicaid: "Source: 'frequency F9 (once/month); one unit per month maximum'"
    supply_bundle: "Source: 'includes all supplies and accessories' - comprehensive monthly supply allowance"
    cannot_bill_bgm: "Source references therapeutic CGM replaces standard BGM - cannot bill A4253/A4259"
  last_verified: "2025-10-29"
  verified_by: "Claude Code"

# Metadata
last_updated: "2025-10-29"
source_documents: ["DM02, DM05, DM06.md"]
reviewed_by: "Claude Code"
---

# A4239 - Therapeutic CGM Supply Allowance (1 Month)

## Clinical Overview

A4239 is a supply allowance for non-adjunctive (therapeutic) continuous glucose monitors, representing **one month of all CGM supplies and accessories**. This includes sensors, transmitters, adhesive patches, and all other necessary accessories for operating the therapeutic CGM system. The supply allowance is used with therapeutic CGM receivers (E2103) that **replace standard blood glucose monitoring**. One unit equals one month of complete supplies. *(Under Review - High Confidence)*

**Important Code Update:** A4239 **replaced K0553 effective January 1, 2023**. Claims for K0553 submitted after 1/1/2023 are denied; suppliers must use A4239. *(Under Review - High Confidence)*

## Coverage Details

### Medicare Coverage Criteria

**Clinical Requirements:**
- Diabetes mellitus diagnosis
- **EITHER:** Insulin-treated **OR** history of problematic hypoglycemia
  - Problematic hypoglycemia defined as: Recurrent glucose <54mg/dL OR level 3 hypoglycemia requiring assistance
- CGM prescribed per FDA indications for glycemic control improvement
- Patient owns therapeutic CGM receiver (E2103)
- Supplies must be on PDAC Product Classification List

**Documentation Requirements:**
- Standard Written Order (SWO) with Written Order Prior to Delivery (WOPD) required
- **In-person or telehealth visit within 6 months prior to initial order**
- **Every 6 months follow-up visits** to document adherence to CGM regimen
- Document insulin treatment OR problematic hypoglycemia history
- Proof of delivery required

**Quantity Limits:**
- **Maximum 3 units per 90 days** (3 months of supplies)
- 1 unit = 1 month supply of all CGM supplies and accessories

**Modifiers:**
- **CG modifier** required when all CGM criteria are met

**Important Notes:**
- **Cannot bill standard BGM supplies** (test strips A4253, lancets A4259) with therapeutic CGM - CGM replaces fingerstick testing *(Under Review - High Confidence)*
- Supply allowance is comprehensive - includes all sensors, transmitters, accessories *(Under Review - High Confidence)*
- Face-to-face visits every 6 months are CRITICAL for ongoing coverage *(Under Review - High Confidence)*
- Must be on PDAC Product Classification List *(Under Review - High Confidence)*

### NY Medicaid (Nassau County)

**Clinical Requirements:**
- Gestational diabetes **OR** Type 1/Type 2 diabetes using therapeutic CGM (E2103)
- CGM replaces standard home BGM for treatment decisions
- Requires insulin treatment OR insulin pump
- Compliant data review visits required

**Documentation Requirements:**
- Physician fiscal order with diabetes diagnosis
- **DVS authorization REQUIRED** before delivery (# code designation)
- Frequency: F9 (once per month)
- Document patient owns therapeutic CGM receiver (E2103)
- One unit encompasses all CGM supplies for the month
- Proof of delivery required

**Important Notes:**
- DVS authorization required BEFORE delivery *(Under Review - High Confidence)*
- Frequency F9 = once per month *(Under Review - High Confidence)*
- One unit per month maximum *(Under Review - High Confidence)*
- Supply allowance is comprehensive - includes sensors, transmitters, all accessories *(Under Review - High Confidence)*
- Cannot bill separate BGM supplies (A4253, A4259) - therapeutic CGM replaces standard monitoring *(Under Review - High Confidence)*

### NY Medicaid (Brooklyn)

**Coverage criteria identical to Nassau County.** All requirements, documentation needs, DVS authorization, frequency, and quantity limits are the same.

## Prescription Checklist for Physicians

**Required Elements:**
- [ ] Patient demographics and Medicaid/Medicare ID
- [ ] Specific code: "A4239 - Supply allowance for non-adjunctive CGM, 1 month"
- [ ] ICD-10 diabetes diagnosis code
- [ ] Document patient owns therapeutic CGM receiver (E2103)
- [ ] Document insulin treatment OR problematic hypoglycemia history
- [ ] Quantity requested (max 3 units per 90 days Medicare, 1 per month Medicaid)
- [ ] Physician signature and date
- [ ] Ordering provider NPI number

**For Medicare:**
- [ ] Standard Written Order with WOPD completed
- [ ] CG modifier included on claim
- [ ] In-person/telehealth visit within 6 months prior documented
- [ ] Schedule every 6 months follow-up visits for adherence monitoring
- [ ] Verify supplies are on PDAC Product Classification List
- [ ] Do NOT order standard BGM supplies (A4253, A4259) with therapeutic CGM
- [ ] Maximum 3 units per 90 days

**For Medicaid:**
- [ ] Valid ICD-10 diabetes diagnosis on prescription
- [ ] DVS authorization must be obtained by supplier before delivery
- [ ] Frequency F9 - one unit per month
- [ ] Document patient owns E2103 receiver
- [ ] Document insulin treatment or insulin pump use
- [ ] Schedule compliant data review visits
- [ ] Do NOT order standard BGM supplies with therapeutic CGM

## Common Denial Reasons

1. **"Code not recognized"** (Medicare, if K0553 used after 1/1/2023) - Old code used. Fix: Use A4239 instead of K0553 for all claims after 1/1/2023. *(Under Review - High Confidence)*

2. **"DVS authorization not obtained"** (Medicaid) - Delivered before authorization. Fix: Supplier must obtain DVS authorization before delivery. *(Under Review - High Confidence)*

3. **"Missing CG modifier"** (Medicare) - CG modifier not included. Fix: Always include CG modifier when billing CGM supplies. *(Under Review - High Confidence)*

4. **"Quantity exceeded"** (Medicare) - More than 3 units per 90 days. Fix: Maximum 3 units (3 months supply) per 90 days. *(Under Review - High Confidence)*

5. **"Frequency exceeded"** (Medicaid) - More than 1 unit per month. Fix: Limit to 1 unit per month (F9 frequency). *(Under Review - High Confidence)*

6. **"6-month visit not documented"** (Medicare) - Missing required face-to-face visit. Fix: Document initial visit within 6 months prior and schedule ongoing 6-month visits. *(Under Review - High Confidence)*

7. **"No CGM receiver"** - Patient doesn't have covered E2103 receiver. Fix: Ensure therapeutic CGM receiver (E2103) is covered before ordering supplies. *(Under Review - High Confidence)*

8. **"Standard BGM supplies billed"** - A4253 or A4259 billed with A4239. Fix: Cannot bill standard BGM supplies with therapeutic CGM - CGM replaces fingerstick testing. *(Under Review - High Confidence)*

9. **"Not on PDAC list"** (Medicare) - Supplies not on Product Classification List. Fix: Verify supplies are PDAC-listed before ordering. *(Under Review - High Confidence)*

## Tips for Approval

**Medicare:**
- Use A4239, not K0553 - code changed effective 1/1/2023 *(Under Review - High Confidence)*
- Always include CG modifier on claims *(Under Review - High Confidence)*
- Document initial face-to-face visit within 6 months before order *(Under Review - High Confidence)*
- Schedule and document ongoing 6-month follow-up visits for adherence *(Under Review - High Confidence)*
- Maximum 3 units per 90 days (do not exceed) *(Under Review - High Confidence)*
- Verify supplies are on PDAC Product Classification List *(Under Review - High Confidence)*
- Do NOT order standard BGM supplies (A4253, A4259) with therapeutic CGM *(Under Review - High Confidence)*
- Ensure patient has covered E2103 receiver before ordering supplies *(Under Review - High Confidence)*

**Medicaid:**
- Supplier must obtain DVS authorization BEFORE delivery *(Under Review - High Confidence)*
- Frequency F9 = one unit per month maximum *(Under Review - High Confidence)*
- Ensure patient has covered E2103 receiver *(Under Review - High Confidence)*
- Document insulin treatment or insulin pump use *(Under Review - High Confidence)*
- Schedule compliant data review visits with provider *(Under Review - High Confidence)*
- Do NOT bill standard BGM supplies (A4253, A4259) with therapeutic CGM *(Under Review - High Confidence)*
- One unit encompasses ALL monthly CGM supplies - sensors, transmitters, accessories *(Under Review - High Confidence)*

## Related Codes

- **E2103** - Non-adjunctive (therapeutic) CGM receiver - The CGM device that these supplies are used with. Must be covered before supplies are reimbursed. *(Under Review - High Confidence)*

- **K0553** - **DISCONTINUED 1/1/2023** - Old code for therapeutic CGM supplies. Medicare crosswalked to A4239. Use A4239 for all claims after 1/1/2023. *(Under Review - High Confidence)*

- **K0554** - **DISCONTINUED 1/1/2023** - Old code for therapeutic CGM receiver. Medicare crosswalked to E2103. *(Under Review - High Confidence)*

- **A4253/A4259** - Test strips/lancets - **Cannot bill with A4239**. Therapeutic CGM replaces fingerstick testing. *(Under Review - High Confidence)*

- **E0607** - Home blood glucose monitor (standard) - **Cannot bill with therapeutic CGM**. Patient uses either standard BGM or therapeutic CGM, not both. *(Under Review - High Confidence)*

- **A4238** - Supply allowance for adjunctive CGM - For adjunctive CGM (E2102 used WITH insulin pump), not therapeutic CGM. Different coverage criteria. *(Under Review - High Confidence)*

- **E2102** - Adjunctive CGM receiver - For use WITH insulin pump; does NOT replace standard BGM. Uses A4238 for supplies, not A4239. *(Under Review - High Confidence)*

## References

- Medicare LCD for Continuous Glucose Monitors
- Medicare Code Crosswalk K0553 â†’ A4239 (effective 1/1/2023)
- NY Medicaid DVS Authorization Requirements
- PDAC Product Classification List
- Source document: DM02, DM05, DM06.md (lines 249-260)
